Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-08-26 00:00:00 ET · period of report 2025-08-22 · accession 0001415889-25-023023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-26 | 2025-08-22 | BBNX | Feider Stephen | CFO | M - OptEx | $5.10 | +4,413 | 49.9K | +10% | +$22.5K |
| D | 2025-08-26 | 2025-08-22 | BBNX | Feider Stephen | CFO | S - Sale+OE | $17.01 | -4,413 | 45.5K | -9% | -$75.1K |
| D | 2025-08-26 | 2025-08-22 | BBNX | Feider Stephen | CFO | M - OptEx | $0.00 | -4,413 | 99.7K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-22 | M | A | 4,413 | $5.10 | 49,916 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-22 | S | D | 4,413 | $17.01 | 45,503 | D | — | — | (F2) The weighted average sale price for the transaction reported was $17.0140 and the range of prices were between $17.00 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-08-22 | M | D | 4,413 | $0.00 | 99,695 | D | $5.10 · — to 2033-09-13 | 4,413 Common Stock | (F3) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |